ICD-11 Diagnostic Guidelines for Mental, Behavioural and Neurodevelopmental Disorders
Since 2011, clinicians and researchers in the Global Clinical Practice Network have participated in field studies that tested the reliability, clinical utility, and global applicability of the ICD-11 Diagnostic Guidelines for Mental, Behavioural, and Neurodevelopmental Disorders.
As the largest and most diverse clinical research network on mental health ever assembled, GCP.Network members and scholars, led by the Field Studies Coordination Group, engaged in systematic, online case-controlled studies and clinic-based field studies to evaluate and inform the proposed revisions to the ICD-11. More than 16,000 mental health practitioners representing more than 160 countries have participated and continue to participate in this dynamic body of research.
After more than a decade of rigorous field studies and regular convenings of clinicians and researchers around the world, the ICD-11 was approved by the World Health Assembly in May 2019 and will go into effect on January 1, 2022.
When viewing the Diagnostic Guidelines, please note that these documents are a pre-publication version available to GCP.Network members only and are to be used for educational purposes. Further edits may be made to these guidelines prior to their publication.
Schizophrenia or Other Primary Psychotic Disorders
Anxiety or Fear-Related Disorders
Obsessive-Compulsive or Related Disorders
Disorders Specifically Associated with Stress
Feeding or Eating Disorders
Disorders of Bodily Distress or Bodily Experience
Disorders Due to Substance Use
Disorders Due to Addictive Behaviours
Impulse Control Disorders
Disruptive Behaviour or Dissocial Disorders
Personality Disorders and Related Traits
Psychological or Behavioural Factors Affecting Disorders or Diseases Classified Elsewhere
Secondary Mental or Behavioural Syndromes Associated with Disorders or Diseases Classified Elsewhere